EP Patent

EP0348155A1 — Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation

Assigned to Rhone Poulenc Rorer International Holdings Inc · Expires 1989-12-27 · 36y expired

What this patent protects

This invention relates to quinolinyl compounds of the general formula: and the use of these compounds as pharmacological agents which are lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties and their pharmaceutical…

USPTO Abstract

This invention relates to quinolinyl compounds of the general formula: and the use of these compounds as pharmacological agents which are lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties and their pharmaceutical compositions and processes for this preparation.

Drugs covered by this patent

Patent Metadata

Patent number
EP0348155A1
Jurisdiction
EP
Classification
—
Expires
1989-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Rhone Poulenc Rorer International Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.